Decitabine Combined with Minimally Myelosuppressive Therapy for Induction of Remission of Pediatric High-Risk Acute Myeloid Leukemia with Chromosome 5q Deletion. a Report of Three Cases
- Resource Type
- Abstract
- Source
- In
Blood 23 November 2021 138 Supplement 1:4427-4427 - Subject
- Language
- ISSN
- 0006-4971